Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost ...

The investment comes as the FDA is pushing drug developers to phase out animal testing in some of the biologic treatments ...

On a positive note, ivonescimab, when used alongside chemotherapy, reduced the risk of disease progression or mortality by 48 ...

The French pharmaceutical giant is acquiring a Cambridge biotech and its rare immunology disease which is already approved in ...

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation , and Evosep Biosystems, a global leader in proteomics solutions, enter a reseller agreement ...

SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation , announces three software ecosystem enhancements at ASMS. These developments will present ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

An outbreak of Salmonella infections traced to cucumbers from Florida is growing. As of May 30, 45 people across 18 states had been infected. Sixteen ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.